InsidersTradesSigma
Follow the AN2 Therapeutics, Inc. share price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Health Care sector, AN2 Therapeutics, Inc. has logged 130 insider filings. Market capitalisation: €226m. The latest transaction was filed on 17 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Aziz Kabeer. All data is accessible without an account.
130
Insider Decl.
n/a
Thresholds
€17m
20 ops.
Buy Volume
€15m
48 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate AN2 Therapeutics, Inc. Strong Buy (bullish), based on 2 analysts. Average price target: US$9.00.
41Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 August 2026
Declarations130 total
1,012,000 shares@ US$6.0082Common StockSEC144:0001972481-26-000263
405,880 shares0Common StockSEC:0001193125-26-351801:0
766 shares0Common StockSEC:0001193125-26-301165:0
2,789 shares0Common StockSEC:0001193125-26-301166:0
2,852 shares0Common StockSEC:0001193125-26-301167:0
5,945 shares@ US$4.1720.015% mcap41.4% of flowCommon StockSEC:0001193125-26-301092:0
265 shares@ US$4.430.0006% mcap100.0% of flowCommon StockSEC:0001193125-26-253622:0
1,192 shares0Common StockSEC:0001193125-26-151626:0
3,775 shares0Common StockSEC:0001193125-26-151628:0
3,775 shares0Common StockSEC:0001193125-26-151632:0
327 shares@ US$1.0622.7% of flowCommon StockSEC:0001193125-26-094490:0
48,375 shares0Common StockSEC:0001193125-26-064166:0
112,250 shares0Common StockSEC:0001193125-26-064151:0
38,000 shares0Common StockSEC:0001193125-26-064141:0
50,000 shares0Common StockSEC:0001193125-26-064176:0
11,560 shares0Common StockSEC:0001193125-26-013041:0
3,650 shares0Common StockSEC:0001193125-26-013038:0
11,560 shares0Common StockSEC:0001193125-26-013035:0
3,604 shares@ US$1.00347.5% of flowCommon StockSEC:0001193125-26-006770:0
3,295 shares@ US$1.00342.2% of flowCommon StockSEC:0001193125-26-006765:0
17,923 shares@ US$1.001429.2% of flowCommon StockSEC:0001193125-26-006763:0
2,819 shares@ US$1.1418.1% of flowCommon StockSEC:0001193125-25-270255:0
765 shares@ US$1.1422.2% of flowCommon StockSEC:0001193125-25-270252:0
25 of 130 declarations
Acerca de AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para enfermedades infecciosas. La empresa cotiza en NASDAQ bajo el ticker ANTX.